How fortunate we are to have one of the top Cancer specialists in the world helping to place our precious donor funds in the most promising areas of Breast Cancer Research. Most recently Dr. Von Hoff, as a featured speaker at the Denver conference of the American Association for Cancer Research, presented the results of a major clinical trial that will provide the foundation for our grants in the Side-Out Protocol. Molecular Profiling and Target Therapies for metastatic breast cancer will utilize a multi-lab investigative approach to deliver therapeutic results to participating patients in real time.  Check out the following link for comments by Dr Von Hoff.